분변 칼프로텍틴 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global faecal calprotectin testing market size is expected to reach USD 14.12 Billion in 2034 from USD 5.14 Billion in 2025, growing at a CAGR of 11.89% during 2026-2034.The faecal calprotectin testing market is gaining momentum as healthcare providers emphasize early detection and monitoring of gastrointestinal diseases. Calprotectin, a biomarker of intestinal inflammation, is increasingly used in diagnosing conditions such as inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. With the global burden of chronic digestive disorders on the rise, demand for reliable, non-invasive testing methods is expected to accelerate.

Technological progress is enhancing diagnostic accuracy and efficiency. Point-of-care testing kits are enabling rapid results, improving patient compliance, and supporting timely treatment decisions. Automated immunoassays and ELISA platforms are streamlining laboratory workflows, while digital data management is integrating test results with electronic health records. These advancements are improving both clinical outcomes and operational efficiency for healthcare systems worldwide.

Future market expansion will be shaped by personalized medicine and preventive healthcare. As clinicians increasingly adopt biomarker-based approaches for disease management, faecal calprotectin testing will play a crucial role in reducing invasive procedures such as colonoscopy. Emerging economies are expected to witness significant growth, supported by rising awareness and expanding healthcare infrastructure. With innovation and accessibility driving adoption, this testing market is positioned as a vital component of the global diagnostic landscape.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Assay

• Enzyme-linked Immunosorbent Assay
• Enzyme Fluroimmunoassay
• Quantitative Immunochromatography

By Application

• Inflammatory Bowel Disease
• Colorectal Cancer
• Others

By End-use

• Hospitals And Clinics
• Diagnostic Laboratories
• Academic And Research Institutes

COMPANIES PROFILED

• BUHLMANN Laboratories, Thermo Fisher Scientific, DiaSorin, bioMerieux, Roche Diagnostics, Siemens Healthineers, Eurofins Scientific, Abbott, Fujirebio, R-Biopharm, ScheBo Biotech, Buhlmann fCAL turbo, Calpro AS, Immundiagnostik, Eagle Biosciences

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY ASSAY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Assay
• 4.2. Enzyme-linked Immunosorbent Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzyme Fluroimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Quantitative Immunochromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Inflammatory Bowel Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Assay
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Assay
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Assay
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Assay
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Assay
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FAECAL CALPROTECTIN TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BUHLMANN Laboratories
  • 9.2.2 Thermo Fisher Scientific
  • 9.2.3 DiaSorin
  • 9.2.4 BioMerieux
  • 9.2.5 Roche Diagnostics
  • 9.2.6 Siemens Healthineers
  • 9.2.7 Eurofins Scientific
  • 9.2.8 Abbott
  • 9.2.9 Fujirebio
  • 9.2.10 R-Biopharm
  • 9.2.11 ScheBo Biotech
  • 9.2.12 Buhlmann FCAL Turbo
  • 9.2.13 Calpro AS
  • 9.2.14 Immundiagnostik
  • 9.2.15 Eagle Biosciences